Ingredient label guide
Calcium D-Glucarate: Labels, Evidence, and Claims
Calcium D-Glucarate is commonly sold in hormone-support and “detox” formulas, but the marketing is more certain than the human evidence. Start with the disclosed compound amount per full serving, any separately declared calcium, and whether a blend hides the individual amount.
Also listed as: calcium glucarate, calcium D-saccharate, calcium saccharate, D-glucaric acid calcium salt, or CDG.
Overview
The glucarate component is the reason this ingredient is marketed
Calcium D-Glucarate is the calcium salt of D-glucaric acid. FDA substance records recognize Calcium D-Glucarate, Calcium Glucarate, Calcium D-Saccharate, and Calcium Saccharate as related names for the anhydrous or tetrahydrate substance. 1
Despite the word calcium, this is not normally chosen as a standard bone-health calcium supplement. The glucarate component drives its use in products positioned around glucuronidation, beta-glucuronidase, hormone metabolism, or detoxification. Those pathway terms explain the marketing concept; they do not establish a clinical outcome.
The first practical distinction is between Calcium D-Glucarate compound mass and separately declared calcium. A label can show 1,000 mg of Calcium D-Glucarate without meaning 1,000 mg of elemental calcium. It is also a different ingredient from calcium gluconate.
Evidence and claims
A plausible pathway is not a proven detox or hormone outcome
A defined glucarate salt: established identity
Calcium D-Glucarate is a recognized chemical identity with anhydrous and tetrahydrate records and several accepted label names.
Beta-glucuronidase: preclinical rationale
Animal studies report reduced beta-glucuronidase activity after glucarate administration, but that does not prove a consumer benefit in humans.
2Detox and estrogen claims: not established
Controlled human evidence has not established Calcium D-Glucarate itself as a reliable way to produce a general detox outcome, lower estrogen, or correct hormone-related symptoms. Human studies of multi-ingredient formulas cannot isolate the effect of Calcium D-Glucarate. 5
Cancer-prevention language: marketing overreach
Laboratory and animal findings do not establish prevention or treatment of cancer in humans and should not be presented as clinical proof.
3Names and forms
Several label names can describe the same glucarate ingredient
Calcium D-Glucarate, Calcium Glucarate, and Calcium D-Saccharate are common names used for the same ingredient family. FDA records list both an anhydrous substance and a tetrahydrate, which includes four water molecules in its chemical formula. 1
Hydration matters when someone tries to calculate calcium from the compound weight. The tetrahydrate is about 12.5% calcium by mass from its formula, while the anhydrous substance has a different composition. If the label does not identify the material clearly or separately declare calcium, an exact elemental-calcium calculation should not be assumed.
What common wording does and does not show
- Calcium D-Glucarate
- The familiar supplement name. The listed milligrams normally describe the compound unless calcium is declared separately.
- Calcium Glucarate or Calcium D-Saccharate
- Recognized alternate names, not automatically different premium forms.
- Anhydrous or tetrahydrate
- These are different hydration states. That detail affects composition but does not prove better absorption or a stronger clinical effect.
- Standalone or multi-ingredient blend
- This changes dose transparency and formula context, not the chemical identity or strength of the evidence.
Read the label
Keep compound weight, calcium, and blend weight separate
There is no established universal clinical dose for the broad detox or hormone claims used on retail products. A clean label comparison therefore starts with disclosed facts rather than deciding that a particular commercial amount is automatically “effective”.
Four label patterns worth recognizing
- Calcium D-Glucarate 500 mg
- The label declares 500 mg of the compound per listed serving. It does not declare 500 mg of elemental calcium.
- Serving size 2 capsules; Calcium Glucarate 1,000 mg
- The 1,000 mg applies to the full two-capsule serving, not automatically to each capsule.
- Calcium D-Glucarate 1,000 mg, providing calcium 125 mg
- The compound amount and the separately stated calcium amount are two related but distinct label facts. Do not add them together as two doses of Calcium D-Glucarate.
- Hormone support blend 700 mg
- A total blend weight does not disclose the individual Calcium D-Glucarate amount. Ingredient order cannot recover a hidden dose.
Front-label phrases such as “estrogen detox”, “liver cleanse”, “hormone reset” or “phase II support” are not substitutes for an exact amount, full serving size, and transparent ingredient list. A named pathway is also not a measured result in the person using the product.
Whole-stack view
A common pairing still needs ingredient-by-ingredient scrutiny
Calcium D-Glucarate often appears with DIM, sulforaphane, or milk thistle. The pairing can explain how a product is positioned, but it does not make the combination clinically validated or allow one ingredient’s evidence to be transferred to the others.
What to compare across products
- Repeated Calcium D-Glucarate
- Check standalone capsules, hormone formulas, and detox-positioned blends for the same ingredient under alternate names.
- Amount per listed serving
- Compare disclosed compound milligrams using the full serving shown on each label.
- Separately declared calcium
- Keep a stated calcium contribution visible without confusing it with the full Calcium D-Glucarate compound mass.
- Hidden blends and co-ingredients
- Preserve total blend weight, named ingredients, and the fact that individual amounts are unavailable.
Safety and evidence limits
Retail dose ranges are not established clinical targets
No widely accepted dietary reference intake or official tolerable upper intake level has been established specifically for Calcium D-Glucarate. In a 2001 evaluation, an Australian Therapeutic Goods Administration committee found limited human data and concluded that long-term safety associated with beta-glucuronidase inhibition could not be established from the evidence provided at that time. 4
Practical limits to keep visible
- No established universal dose
- Amounts common in retail products should not be presented as proven doses for detoxification, estrogen lowering, hormone symptoms, or cancer prevention.
- Limited human safety evidence
- Short preliminary experience is not the same as a deep evidence base for long-term or high-dose use.
- Calcium contribution
- If calcium is separately declared, include it when reviewing the wider calcium stack. Do not infer an exact amount from compound mass unless the relevant form is known.
- Pregnancy and breastfeeding
- Safety evidence is insufficient for routine self-directed use in these contexts.
- Symptoms are not proof of a pathway
- Changes in bloating, bowel habits, cycle symptoms, or general well-being cannot establish that the supplement changed glucuronidation or hormone clearance.
The cautious reading is straightforward: a transparent label makes the product easier to compare, but transparency does not convert a proposed mechanism into proven effectiveness or long-term safety.
Medicines and extra care
The interaction concern is plausible, not clinically mapped
Glucuronidation is an important pathway in the handling of many medicines, so changing glucuronide metabolism creates a theoretical interaction concern. Specific Calcium D-Glucarate drug interactions, their magnitude, and any spacing rules have not been established in controlled human studies. People using regular medicines, hormone therapy, or cancer treatment should review the exact product with a pharmacist or treating clinician. 4
NutriDetector approach
How NutriDetector reads Calcium D-Glucarate labels
The analysis checks supported Calcium D-Glucarate names, the disclosed compound amount and unit, serving context, separately stated calcium when present, blend transparency, and the surrounding formula. Compound mass, separately declared calcium, and total blend weight remain distinct label details.
The result is limited to the submitted label. It cannot confirm hydration state when that detail is not disclosed, laboratory-test identity or actual calcium content, measure beta-glucuronidase activity or hormone levels, prove a detox outcome, clear medicine interactions, or decide personal suitability. Compare extracted details with the original Supplement Facts panel before using the interpretation.
Analyze the full formula
Compare the disclosed amount, serving size, calcium, and blend transparency.
Compare the disclosed Calcium D-Glucarate amount, serving size, separately stated calcium, and blend transparency across the full formula. NutriDetector keeps compound weight, calcium contribution, and hidden blend totals separate so unlike quantities are not treated as equivalent.
Questions and boundaries
Calcium D-Glucarate supplement FAQ
Is Calcium D-Glucarate the same as a regular calcium supplement?
No. It is a calcium salt, but supplement marketing focuses on the glucarate component and proposed glucuronidation-related effects. The Calcium D-Glucarate compound amount is not the same as an elemental-calcium amount.
Are Calcium D-Glucarate, Calcium Glucarate, and Calcium D-Saccharate the same?
They are recognized names for the same ingredient family. A label may also specify anhydrous material or a tetrahydrate. Those hydration states change chemical composition but do not independently prove better absorption or efficacy.
Does Calcium D-Glucarate detox the body?
That claim is too broad. Beta-glucuronidase inhibition provides a mechanistic rationale, supported mainly by laboratory and animal work, but controlled human supplement evidence has not established a general detox outcome.
Does Calcium D-Glucarate lower estrogen?
It has not been established in controlled human supplement trials as a reliable way to lower estrogen or treat hormone-related symptoms. Pathway explanations and formula positioning should not be presented as measured hormone outcomes.
Why is Calcium D-Glucarate paired with DIM?
Both are commonly used in products marketed for estrogen-metabolism support, so the pairing fits that product story. It does not prove that the combination is clinically validated or appropriate for every person.
What do the milligrams on a Calcium D-Glucarate label mean?
They usually describe the Calcium D-Glucarate compound per listed serving. Check the full serving size, and keep any separately declared calcium amount distinct from the compound mass.
How much calcium does Calcium D-Glucarate provide?
It depends on the chemical form. The tetrahydrate is about 12.5% calcium by formula weight, while anhydrous material differs. Use a separately declared calcium value when available rather than assuming every product uses the same form.
Can Calcium D-Glucarate interact with medicines?
Glucuronidation is an important pathway in the handling of many medicines, so changing glucuronide metabolism creates a theoretical interaction concern. Specific Calcium D-Glucarate drug interactions, their magnitude, and any spacing rules have not been established in controlled human studies. People using regular medicines, hormone therapy, or cancer treatment should review the exact product with a pharmacist or treating clinician.
What does NutriDetector check on a Calcium D-Glucarate label?
NutriDetector reviews supported Calcium D-Glucarate names, the disclosed compound amount per listed serving, separately stated calcium when present, serving context, blend transparency, and the surrounding formula. Compound mass, separately declared calcium, and total blend weight remain separate label details.
Scientific references and safety sources
- U.S. Food and Drug Administration, Global Substance Registration System. Calcium Saccharate and Calcium Saccharate Anhydrous substance records. FDA GSRS tetrahydrate record and FDA GSRS anhydrous record.
- Dwivedi C, Heck WJ, Downie AA, Larroya S, Webb TE. Effect of calcium glucarate on beta-glucuronidase activity and glucarate content of certain vegetables and fruits. Biochemical Medicine and Metabolic Biology. 1990;43(2):83-92. PubMed.
- Walaszek Z, Szemraj J, Narog M, et al. Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention. Cancer Detection and Prevention. 1997;21(2):178-190. PubMed.
- Australian Therapeutic Goods Administration, Complementary Medicines Evaluation Committee. CMEC 30 Extracted Ratified Minutes: confirmation of Recommendation 29.5 on Calcium glucarate. Australian TGA.
- Memorial Sloan Kettering Cancer Center. Calcium Glucarate. MSKCC.